Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelin in heart failure.

G Sütsch1, M Barton

  • 1Division of Cardiology, Department of Medicine, University Hospital Zürich, CH 8091 Zürich, Switzerland.

Current Hypertension Reports
|September 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of organic fruit juices on physicochemical, microbiological, and antioxidative aspects of fermented whey beverages from organic goat and cow milk, produced at laboratory and industrial scales.

Journal of dairy science·2024
Same author

Assessing a Suitable Radiotherapy Utilisation Benchmark for Older Patients With Head and Neck Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET/CT images.

Physical and engineering sciences in medicine·2023
Same author

Health Economic and Health Service Issues of Palliative Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Factors Associated With Radiotherapy Utilisation In New South Wales, Australia: Results From The 45 and Up Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Sidney George Shaw, DPhil (1948-2017).

Physiological research·2019
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

Congestive heart failure involves impaired blood flow due to cardiac pumping issues. Endothelin-1, a vasoconstrictor, plays a key role in this condition, making it a potential therapeutic target.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pathophysiology

Background:

  • Congestive heart failure (CHF) stems from cardiac muscle pumping failure and compensatory cardiovascular adaptations.
  • CHF is characterized by increased vasoconstriction and reduced vasodilation during physical activity.
  • Compensatory mechanisms, including sympathetic nervous system activation and neurohormone release (angiotensin II, catecholamines, vasopressin), elevate vasoconstrictor tone.

Purpose of the Study:

  • To investigate the role of the endothelin system in the pathophysiology of congestive heart failure.
  • To explore the imbalance between vasodilators (e.g., nitric oxide) and vasoconstrictors (e.g., endothelin-1) in CHF.
  • To assess the therapeutic potential of targeting the endothelin system in CHF.

Main Methods:

Related Experiment Videos

  • Analysis of vasoactive substance release and inactivation by the vascular endothelium in CHF.
  • Evaluation of the effects of endothelin-1, including vasoconstriction, antinatriuresis, and mitogenesis.
  • Review of clinical research on endothelin receptor antagonists in CHF.

Main Results:

  • CHF exhibits a significant imbalance with diminished vasodilators and increased vasoconstrictors like endothelin-1.
  • Endothelin-1 demonstrates potent vasoconstrictor, antinatriuretic, and mitogenic properties.
  • The endothelin system's broad actions are implicated in the detrimental progression of CHF.

Conclusions:

  • The endothelin system is critically involved in the pathophysiology of congestive heart failure.
  • Endothelin-1's multifaceted actions contribute to the severity and lethality of CHF.
  • Targeting the endothelin system with specific antagonists presents a promising avenue for future CHF therapeutic strategies.